Sectors
ATOS
Atossa Therapeutics, Inc.
2.50
2 x 1.82
2 x 3.26
bid
ask
-
0.08
3.10%
2 @ 04:10 PM
2.50 +0.00 (0.00%)
| Ytd | -71.75% | |
| 1y | -78.07% |
2.50
day range
2.59
1.70
52 week range
19.35
| Open | 2.57 | Prev Close | 2.58 | Low | 2.50 | High | 2.59 | Mkt Cap | 24.95M |
| Vol | 53.19K | Avg Vol | 155.47K | EPS | -4.34 | P/E | N/A | Forward P/E | -3.81 |
| Beta | 1.23 | Short Ratio | 14.73 | Inst. Own | 28.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 2.33 | 200-d Avg | 5.83 | 1yr Est | 6.00 |
| Income Statement | |||
| Operating Expenses | 8.69M | ||
| Research and Development Expense | 4.90M | ||
| Selling, General and Administrative Expense | 3.80M | ||
| Operating Income | -8.69M | ||
| Net Income | -8.49M | ||
| Net Income Common Stock | -8.49M | ||
| Net Income Common Stock (USD) | -8.49M | ||
| Consolidated Income | -8.49M | ||
| Earnings per Basic Share | -0.95 | ||
| Earnings per Basic Share (USD) | -0.95 | ||
| Earnings per Diluted Share | -0.95 | ||
| Earning Before Interest & Taxes (EBIT) | -8.49M | ||
| Earning Before Interest & Taxes (USD) | -8.49M | ||
| Weighted Average Shares | 8.91M | ||
| Weighted Average Shares Diluted | 8.91M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.20M | ||
| Cash and Equivalents (USD) | 26.20M | ||
| Current Assets | 31.01M | ||
| Total Assets | 32.28M | ||
| Current Liabilities | 5.45M | ||
| Total Liabilities | 5.45M | ||
| Accumulated Retained Earnings (Deficit) | -264.64M | ||
| Shareholders Equity | 26.83M | ||
| Shareholders Equity (USD) | 26.83M | ||
| Assets Non-Current | 1.27M | ||
| Trade and Non-Trade Payables | 1.98M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.00K | ||
| Net Cash Flow from Financing | 4.02M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.62M | ||
| Issuance (Purchase) of Equity Shares | 4.02M | ||
| Net Cash Flow from Operations | -9.64M | ||
| Share Based Compensation | 815.00K | ||